TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 9.57%179.4M | ---- | 87.86%202.22M | ---- | 225.54%163.73M | ---- | -80.46%107.64M | ---- | -156.11%-130.42M |
Profit adjustment | ||||||||||
Interest expense - adjustment | ---- | -12.29%150.48M | ---- | -18.49%334.66M | ---- | -19.78%171.55M | ---- | -7.36%410.56M | ---- | -5.27%213.84M |
Investment loss (gain) | ---- | 149.48%22.18M | ---- | 42.13%-58.65M | ---- | -88.97%-44.83M | ---- | 39.75%-101.35M | ---- | 78.58%-23.72M |
Impairment and provisions: | ---- | 295.00%26.16M | ---- | -62.26%55.04M | ---- | -95.87%6.62M | ---- | -60.99%145.85M | ---- | 9.84%160.57M |
-Other impairments and provisions | ---- | 295.00%26.16M | ---- | -62.26%55.04M | ---- | -95.87%6.62M | ---- | -60.99%145.85M | ---- | 9.84%160.57M |
Revaluation surplus: | ---- | 345.31%120.7M | ---- | -78.09%96.66M | ---- | -110.64%-49.2M | ---- | 190.14%441.22M | ---- | 382.40%462.65M |
Asset sale loss (gain): | ---- | -43.98%676.24K | ---- | 23.95%1.61M | ---- | 139.44%1.21M | ---- | -13.73%1.3M | ---- | 97.42%504.18K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -43.98%676.24K | ---- | 23.95%1.61M | ---- | 139.44%1.21M | ---- | -13.73%1.3M | ---- | 97.42%504.18K |
Depreciation and amortization: | ---- | 1.52%93.21M | ---- | 9.42%186.53M | ---- | 10.78%91.81M | ---- | 8.95%170.47M | ---- | 11.52%82.88M |
-Amortization of intangible assets | ---- | 23.94%34.84M | ---- | 23.29%59.47M | ---- | 22.15%28.11M | ---- | 27.16%48.23M | ---- | 29.68%23.01M |
-Other depreciation and amortization | ---- | 6.82%9.2M | ---- | 13.69%17.42M | ---- | 34.28%8.62M | ---- | 21.86%15.32M | ---- | 4.83%6.42M |
Exchange Loss (gain) | ---- | 114.25%167.33K | ---- | 77.42%-387.8K | ---- | 60.72%-1.17M | ---- | -8.83%-1.72M | ---- | -1,163.63%-2.99M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 235.82%503.58M | ---- | -134.29%-415.29M | ---- | -115.29%-370.78M | ---- | 175.60%1.21B | ---- | 234.87%2.43B |
Accounts payable increase (decrease) | ---- | 58.45%-215.75M | ---- | -187.26%-858.65M | ---- | -15.26%-519.22M | ---- | -75.19%-298.91M | ---- | -326.41%-450.47M |
Special items of business | ---- | -73.24%-23.96M | ---- | 86.81%-11.04M | ---- | 87.69%-13.83M | ---- | -64.98%-83.66M | ---- | -27.93%-112.39M |
Adjustment items of business operations | 538.06%5.22B | 260.06%880.8M | 139.85%752.02M | -121.87%-456.26M | -48.58%-1.19B | -120.09%-550.29M | -76.14%-1.89B | 330.34%2.09B | 1.60%-801.95M | 329.18%2.74B |
Net cash from operations | 538.06%5.22B | 251.89%856.85M | 139.85%752.02M | -123.34%-467.3M | -48.58%-1.19B | -121.48%-564.12M | -76.14%-1.89B | 309.38%2B | 1.60%-801.95M | 304.73%2.63B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -49.79%34.21M | -46.10%33.01M | -96.15%706.14K | 70.80%90.97M | -7.51%68.14M | 124.44%61.24M | 139.68%18.35M | -58.27%53.26M | 13.47%73.67M | -44.60%27.29M |
Sale of fixed assets | 11,140.03%4.6M | 380.05%1.53M | 68.74%385.13K | 138.01%719.94K | -88.31%40.92K | 41.57%318.1K | -10.56%228.23K | -76.45%302.48K | -32.12%350.03K | 18.68%224.69K |
Purchase of fixed assets | 44.34%-77.04M | 50.05%-52M | 24.77%-19.77M | 34.17%-149.39M | 18.67%-138.42M | -11.03%-104.12M | 77.30%-26.28M | -2.86%-226.95M | -157.68%-170.2M | -164.69%-93.78M |
Recovery of cash from investments | -85.65%220.55M | -91.09%144.73M | -99.82%1.93M | --1.95B | 194.05%1.54B | 746.77%1.62B | 1,292.15%1.07B | ---- | -43.98%522.6M | -31.36%191.78M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.28B | ---- | ---- |
Net cash from investment operations | -87.57%182.32M | -91.95%127.27M | -101.57%-16.75M | 230.25%1.89B | 243.90%1.47B | 1,159.90%1.58B | 3,584.16%1.07B | -203.95%-1.45B | -54.26%426.43M | -57.22%125.52M |
Net cash before financing | 1,864.82%5.4B | -3.26%984.11M | 189.68%735.27M | 158.58%1.42B | 173.21%274.94M | -63.03%1.02B | 25.60%-819.87M | 25.07%550.62M | -420.00%-375.52M | 378.13%2.75B |
Cash flow from financing activities | ||||||||||
New borrowing | -11.02%7M | -11.02%7M | --7M | -91.69%7.87M | -91.79%7.87M | -84.12%7.87M | ---- | 846.97%94.7M | -13.72%95.78M | 395.48%49.55M |
Refund | 48.24%-4.24B | 32.25%-3.41B | 11.38%-1.68B | 30.68%-9.5B | 24.42%-8.19B | 38.69%-5.04B | 52.82%-1.9B | -37.28%-13.7B | -38.75%-10.83B | -82.78%-8.22B |
Issuance of bonds | -22.22%6B | -45.10%3.24B | -56.40%1.46B | -28.60%8.72B | -22.98%7.71B | -14.51%5.89B | -33.58%3.35B | 2.29%12.22B | 11.91%10.01B | -4.64%6.89B |
Dividends paid - financing | -9.16%-300.56M | 11.04%-190.08M | -6.33%-142.36M | 32.32%-357.08M | 32.34%-275.34M | 19.62%-213.67M | 2.22%-133.89M | 22.20%-527.63M | -21.60%-406.95M | 12.02%-265.82M |
Other items of the financing business | 61.89%-65.28M | 74.97%-38.8M | 54.67%-43.64M | 1.18%-200.08M | -166.48%-171.31M | -277.23%-154.99M | -428.22%-96.27M | -16.60%-202.46M | 3.78%-64.29M | 1.51%-41.09M |
Net cash from financing operations | 252.59%1.4B | -181.37%-400.96M | -132.52%-398.21M | 37.51%-1.33B | 23.47%-917.09M | 131.10%492.74M | 40.57%1.22B | -290.44%-2.13B | -241.55%-1.2B | -166.06%-1.58B |
Effect of rate | -253.40%-1.1M | -114.25%-167.33K | -81.47%271.78K | -77.42%387.8K | -76.02%716.41K | -60.72%1.17M | -32.73%1.47M | 8.83%1.72M | 212.04%2.99M | 1,163.63%2.99M |
Net Cash | 1,159.16%6.8B | -61.38%583.16M | -16.74%337.06M | 106.09%95.82M | 59.20%-642.15M | 29.34%1.51B | 275.44%404.83M | -201.18%-1.57B | -263.27%-1.57B | -17.13%1.17B |
Begining period cash | 0.72%13.39B | 0.72%13.39B | 0.72%13.39B | -10.58%13.3B | -10.58%13.3B | -10.58%13.3B | -10.58%13.3B | 11.70%14.87B | 11.70%14.87B | 11.70%14.87B |
Cash at the end | 59.56%20.19B | -5.62%13.98B | 0.20%13.73B | 0.72%13.39B | -4.84%12.66B | -7.68%14.81B | -6.41%13.7B | -10.58%13.3B | -6.85%13.3B | 8.96%16.04B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.